Effects of tobramycin ophthalmic: A Synthesis of Findings from 7 Studies

  1. Home
  2. Effects of tobramycin ophthalmic
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of tobramycin ophthalmic: A Synthesis of Findings from 7 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of tobramycin ophthalmic: A Synthesis of Findings from 7 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Tobramycin ophthalmic solution has been shown to be effective in treating bacterial conjunctivitis in several studies. 7 demonstrated that tobramycin ophthalmic solution is effective in treating bacterial conjunctivitis and is safe. 4 showed that tobramycin ophthalmic solution was equivalent in efficacy to azithromycin eye drops for treating bacterial conjunctivitis. 5 demonstrated that tobramycin ophthalmic solution was equivalent in efficacy to fusidic acid eye drops for treating bacterial conjunctivitis. These results suggest that tobramycin ophthalmic solution is effective for the treatment of bacterial conjunctivitis and is safe.

Benefits and Risks

Benefits Summary

Tobramycin ophthalmic solution has been shown to be effective in treating bacterial conjunctivitis in several studies. It has also been shown to be safe. 4 showed that tobramycin ophthalmic solution was equivalent in efficacy to azithromycin eye drops for treating bacterial conjunctivitis. 5 demonstrated that tobramycin ophthalmic solution was equivalent in efficacy to fusidic acid eye drops for treating bacterial conjunctivitis.

Risks Summary

Risks associated with the use of tobramycin ophthalmic solution are rarely reported. However, 7 found some reports of eye irritation and conjunctival hyperemia after use of tobramycin ophthalmic solution. These side effects were not serious.

Comparison Between Studies

Similarities Between Studies

Multiple studies have demonstrated tobramycin ophthalmic solution to be effective for bacterial conjunctivitis and safe. However, these studies primarily focused on comparisons with other ophthalmic solutions, with limited research on the effectiveness and safety of tobramycin ophthalmic solution alone.

Differences Between Studies

Although multiple studies have evaluated the effectiveness and safety of tobramycin ophthalmic solution, the results need to be interpreted cautiously due to differences in methods and participants across studies. For example, 7 compared tobramycin ophthalmic solution to other ophthalmic solutions, while 4 compared it to azithromycin eye drops.

Consistency and Contradictions in Findings

Multiple studies suggest tobramycin ophthalmic solution is effective and safe for treating bacterial conjunctivitis. However, interpreting the results requires caution due to different methods and participants in each study. For example, 7 compared tobramycin ophthalmic solution to other ophthalmic solutions, while 4 compared it to azithromycin eye drops. More research is necessary to draw definitive conclusions about the effectiveness and safety of tobramycin ophthalmic solution.

Cautions for Applying Findings to Real Life

Tobramycin ophthalmic solution has been shown to be effective for bacterial conjunctivitis. However, it may not be effective for all cases of bacterial conjunctivitis. Additionally, tobramycin ophthalmic solution can cause side effects such as eye irritation and conjunctival hyperemia. Therefore, it is important to follow your doctor's instructions when using tobramycin ophthalmic solution.

Limitations of Current Research

Research on tobramycin ophthalmic solution is still inadequate. Research on the effectiveness and safety of tobramycin ophthalmic solution alone is limited. Furthermore, interpreting results requires caution due to differences in methods and participants across studies. More research is needed to draw definitive conclusions regarding the effectiveness and safety of tobramycin ophthalmic solution.

Future Research Directions

Further research is needed on the effectiveness and safety of tobramycin ophthalmic solution. Specifically, research focusing on the effectiveness and safety of tobramycin ophthalmic solution alone is crucial. Additionally, standardizing methods and participants across studies will improve the accuracy of result interpretation.

Conclusion

Multiple studies have shown that tobramycin ophthalmic solution is effective for treating bacterial conjunctivitis. However, it may not be effective for all cases of bacterial conjunctivitis. Additionally, tobramycin ophthalmic solution can cause side effects such as eye irritation and conjunctival hyperemia. Therefore, it is important to follow your doctor's instructions when using tobramycin ophthalmic solution. Further research is needed on the effectiveness and safety of tobramycin ophthalmic solution.

Literature analysis of 7 papers
Positive Content
7
Neutral Content
0
Negative Content
0
Article Type
6
1
0
0
7
1.

Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.

Author: GrovesL, ShellenbergerM K, DavisC S

Antispastic efficacy
Greater tolerability
Improved muscle strength

Tizanidine, baclofen, and diazepam were all found to be effective in decreasing excessive muscle tone in patients with multiple sclerosis or cerebrovascular lesions. Tizanidine was shown to have the best tolerability, and it had the greatest improvement in muscle strength compared to the other two medications.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

2.

Pharmacokinetic comparison of two 4 mg tablet formulations of tizanidine.

Author: Al-GhazawiMutasim, AlzoubiMamoun, FaidiBashar

Bioequivalent formulations
Smoking decreases efficacy

Tizanidine PIC® 4 mg tablets are bioequivalent to Sirdalud® 4 mg tablets. Smoking was found to decrease the peak plasma concentration and area under the curve of tizanidine.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

3.

Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.

Author: ComstockTimothy L, PaternoMichael R, BatemanKirk M, DecoryHeleen H, GearingerMatthew

Minimal IOP effect
Ocular inflammation treatment

Loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension (LE/T) is used for steroid-responsive inflammatory ocular conditions where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. This study found that LE/T is safe for patients 18 years and older and has a minimal effect on intraocular pressure (IOP).

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.

Author: ProtzkoEugene, BowmanLyle, AbelsonMark, ShapiroAron,

Bacterial eradication
Well tolerated

Azithromycin 1% in DuraSite is safe and can be administered in a regimen of less frequent doses than can tobramycin, while producing an equivalent clinical outcome.

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

5.

Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.

Author: JacksonW Bruce, LowDonald E, DattaniDan, WhitsittPaul F, LeederRandall G, MacDougallRosemary

Bacterial conjunctivitis treatment

This study compares the clinical and microbiologic efficacy, safety, and acceptability of fusidic acid viscous drops and tobramycin ophthalmic solution in the treatment of suspected bacterial conjunctivitis.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

6.

Fixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution for inflammation after cataract surgery: a randomized, comparative, active treatment-controlled trial.

Author: BarraquerR I, Alvarez de ToledoJ P, MontanéD, EscotoR M, Garcia TorresC, Bennani-TazziM

Cataract surgery recovery

A fixed-dose combination of 0.1% diclofenac plus 0.3% tobramycin ophthalmic solution was compared with 0.1% diclofenac and 0.3% tobramycin in patients undergoing cataract extraction.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

7.

Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis.

Author: BloomP A, LeemingJ P, PowerW, LaidlawD A, CollumL M, EastyD L

Effective
Safe

This study compared the efficacy of a new topical ciprofloxacin ophthalmic formulation with tobramycin ophthalmic solution in treating blepharitis and blepharoconjunctivitis. Both treatments were effective and safe, with ciprofloxacin showing slightly better bacteriological eradication.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.